Agile Therapeutics to Report First Quarter 2022 Financial Results and Provide Business Update on Thursday, May 12, 2022
03 5월 2022 - 8:30PM
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare
company, today announced it will report first quarter 2022
financial results after the market close on Thursday, May 12,
2022. Following the release, the Company will host a live
conference call and webcast at 4:30 p.m. ET to discuss
the Company’s financial results and provide a business update.
Date |
Thursday, May 12, 2022 |
Time |
4:30 p.m. ET |
Webcast (live and archived) |
Events & Presentations |
Dial-in numbers |
(888) 330-2454 (U.S. toll-free) or (240) 789-2714 |
Conference ID |
7871426 |
|
|
Investors interested in listening to the conference call may do
so by dialing (888) 330-2454 for domestic callers or (240) 789-2714
for international callers. The Conference ID is 7871426. A live
webcast will be available in the Events and Presentations section
of the Investor Relations page at
https://ir.agiletherapeutics.com/events-and-presentations/, or by
clicking here.
Please log in approximately 10 minutes prior to the scheduled
start time. The archived webcast will be available in the Events
and Presentations section of the company's website.
About Agile Therapeutics, Inc.Agile
Therapeutics is a women's healthcare company dedicated to
fulfilling the unmet health needs of today’s women. Our
product and product candidates are designed to provide women with
contraceptive options that offer freedom from taking a daily pill,
without committing to a longer-acting method. Our initial
product, Twirla®, (levonorgestrel and ethinyl estradiol), a
transdermal system, is a non-daily prescription contraceptive.
Twirla is based on our proprietary transdermal patch technology,
called Skinfusion®, which is designed to allow drug delivery
through the skin. For more information, please visit the company
website at www.agiletherapeutics.com. The
Company may occasionally disseminate material, nonpublic
information on the Company’s website.
Contact: Matt RileyHead of Investor
Relations & Corporate
Communicationsmriley@agiletherapeutics.com
Agile Therapeutics (NASDAQ:AGRX)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Agile Therapeutics (NASDAQ:AGRX)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024